We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Cepheid Introduces GeneXpert® 16-Site System

Read time: Less than a minute

Cepheid has introduced the GeneXpert® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology.

Cepheid claims that, batch processing is no longer the only option, as Cepheid's GeneXpert 16-Site System has the flexibility to run up to 16 different molecular tests simultaneously, with minimal hands-on time, thereby delivering the power of true on-demand testing.

The GeneXpert System is expected to provide the molecular laboratory with the ability to start test runs anytime samples are collected-24 hours a day, 365 days a year.

"Cepheid's GeneXpert technology represents a true paradigm shift in the practical implementation of real-time PCR," said Cepheid CEO John Bishop.

"No longer limited by batch processing protocols and laborious manual procedures, laboratorians can now have access to critical answers when they need them."

"In addition, laboratories will have a unique ability to run the exact same tests on a high through-put main lab system or on a desktop system in a satellite lab."

The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences.

The GeneXpert® 16-Site System is configurable from 4 to16 modules, allowing users to expand their system as demand for assays increase.

Shipments of the GeneXpert 16-Site System are expected to begin in the 4th quarter of 2006.

The system will support the current menu of tests available on the GeneXpert 4-Site System and all GeneXpert tests in the product pipeline.